“It certainly seems that we're moving into medical management of advanced diseases,” says J. Christopher Webster, MD, FACS.
In this video, J. Christopher Webster, MD, FACS, makes his predictions for future advancements in urology over the next several years. Webster is a urologist with Colorado Urology in Westminster. He was interviewed at the 2022 LUGPA Annual Meeting in Chicago, Illinois.
UGN-102 reaches nearly 80% complete response rate in low-grade intermediate-risk NMIBC
November 30th 2023Primary chemoablative therapy with the mitomycin-containing reverse thermal gel UGN-102 induced complete responses in nearly 4 out of 5 patients with low-grade intermediate-risk non–muscle-invasive bladder cancer.